InvestorsHub Logo
Followers 18
Posts 1020
Boards Moderated 0
Alias Born 12/18/2020

Re: None

Tuesday, 05/25/2021 11:30:24 AM

Tuesday, May 25, 2021 11:30:24 AM

Post# of 2447
https://finance.yahoo.com/news/curative-biotechnology-inc-files-2021-135000170.html

Dimiter Dimitrov, Ph.D.

This guy is light years ahead of Harry in this industry. Charles looks to be getting there but Harry's messy past maybe taking longer than it should have. Since Harry's smear from the Ebola "mis-information" in Africa, Charles may have to clean up verbiage(a lot of it) to rectify that Enzolytics Inc. is developing a viable product for the bio-tech world.

Granted Dimiter's medicines in development is a different path than Harry's, but much further ahead. They(Curative Biotech) look to be better organized and goal oriented.

Enzolytics Inc. maybe headed down a path but direction is unclear and not specific to investors. Organized, something is missing in Enzolytics mission statement to how the team will achieve through the path.

When Enzolytics Inc. has their ducks in a row, their "unknown" contractor(IMMB) will start producing the compounds ITV1-4 and generating revenue both in a wholistic therapy for over the counter and medicinal compound for treating viruses and diseases. This should garner enough for generating revenue.

IMMB getting current- Harry has to get IMMB current, if he wants to see value($). Granted he doesn't have to abide by a lot of the rules under a PENNY stock. But if he is looking to turn a profit on his venture with IMMB that is in "control"(speculation) of ENZC. Pink Current has to be at the fore front. If he cares only about curing the world and not so much money, then we are all SOL.

This information is only for the intent of IMMB investors and this information is only speculatively driven based on all present information to date.